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Background: Quick remediation should occur after critically abnormal potassium levels 
are detected by the medical laboratory in blood from emergency department (ED) 
patients.  Critical potassium levels can be elevated (“HyperK+“) or decreased 
(“HypoK+“). HyperK+ and  HypoK+ can both lead to avoidable patient harm by causing 
heart rhythm problems, which can be harmful or lethal.  Also, Continuous Quality 
Improvement (CQI) could be enhanced by the creation of an electronic “audit trail” to 
track these remediations, which involve detection, notification, action-upon, and 
documentation steps (D1-N-A-D2).   HyperK+ and  HypoK+ are a logical first target to 
ameliorate inefficiencies of D1-N-A-D2, because of the frequency of occurrence of these 
problems in the ED, because the appropriate rapid ED response is clear, and because 
failures of D1-N-A-D2. can hurt or kill patients.  Hypothesis: An automated D1-N-A-D2, 
plus audit path, can be created, then merged with a to-be-created standing ED order 
set, to hasten the treatment of HyperK+ and HypoK+.  Methods:  (1) A standing order set 
will be adopted, to permit nurses to administer appropriate treatments to patients with 
either HyperK+ or HypoK+, without prior physician notification.  Oral or intravenous 
potassium, as appropriate, will remediate HypoK+,  Administration of insulin plus 
glucose, calcium, sodium bicarbonate, and sodium polystyrene resin will ameliorate 
HyperK+. Order sets will be created after input from physician and nursing personnel.  
(Re-obtaining of blood from patients in whom HyperK+ is thought to be a false positive 
result, due to hemolysis of the blood sample, will be permitted).  (2)  “Electronic loop”:  
Engineers will create an electronic pathway to enable the rapid electronic notification of 
appropriate medical personnel, after critical HyperK+ or HypoK+ have been detected.  
This will enable and drive nurses to action.  Actions can be electronically audited via 
review of digital  PyxisTM medication administration machine records, matching 
medication withdrawals for specific patients to specific incidences of HyperK+ and 
HypoK+.   Time to nurse action will be documented.   Data during implementation of D1-
N-A-D2 will be compared to prior historical control data, to determine whether the newly 
created process delivers appropriate care more quickly to patients with critically 
abnormal K+ values.   (In addition, it is anticipated that electronic review of laboratory 
data for the historical controls will reveal total system failures for some patients; some 
patients with HyperK+ and/or HypoK+ might not have been treated at all for their 
potassium abnormality during their time in the ED.)  Results: Time to treatment for 
HyperK+ and HypoK+ patients, and % of patients with HyperK+ and HypoK+ who 
represent total system failures, before vs. after implementation of the pervasive 
computing protocol, will be determined.  Conclusion:  It is anticipated that a pervasive 
computing environment can be created to facilitate implementation of a standing 
medication order set, to enable more rapid D1-N-A-D2 after critical values of HyperK+ or 
HypoK+ are detected in the blood of emergency department patients.  Also, this 
environment will decrease the failure-to-treat rate for critical HyperK+ and HypoK+. 
 
